120 related articles for article (PubMed ID: 26374157)
1. [PDLIM2 and Its Role in Oncogenesis--Tumor Suppressor or Oncoprote?].
Maryáš J; Bouchal P
Klin Onkol; 2015; 28 Suppl 2():2S40-6. PubMed ID: 26374157
[TBL] [Abstract][Full Text] [Related]
2. PDLIM2 regulates transcription factor activity in epithelial-to-mesenchymal transition via the COP9 signalosome.
Bowe RA; Cox OT; Ayllón V; Tresse E; Healy NC; Edmunds SJ; Huigsloot M; O'Connor R
Mol Biol Cell; 2014 Jan; 25(1):184-95. PubMed ID: 24196835
[TBL] [Abstract][Full Text] [Related]
3. PDLIM2: Signaling pathways and functions in cancer suppression and host immunity.
Guo ZS; Qu Z
Biochim Biophys Acta Rev Cancer; 2021 Dec; 1876(2):188630. PubMed ID: 34571051
[TBL] [Abstract][Full Text] [Related]
4. Oncovirus Kaposi sarcoma herpesvirus (KSHV) represses tumor suppressor PDLIM2 to persistently activate nuclear factor κB (NF-κB) and STAT3 transcription factors for tumorigenesis and tumor maintenance.
Sun F; Xiao Y; Qu Z
J Biol Chem; 2015 Mar; 290(12):7362-8. PubMed ID: 25681443
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic repression of PDZ-LIM domain-containing protein 2: implications for the biology and treatment of breast cancer.
Qu Z; Fu J; Yan P; Hu J; Cheng SY; Xiao G
J Biol Chem; 2010 Apr; 285(16):11786-92. PubMed ID: 20185823
[TBL] [Abstract][Full Text] [Related]
6. PDLIM2 acts as a cancer suppressor gene in non-small cell lung cancer via the down regulation of NF-κB signaling.
Shi H; Ji Y; Li W; Zhong Y; Ming Z
Mol Cell Probes; 2020 Oct; 53():101628. PubMed ID: 32621848
[TBL] [Abstract][Full Text] [Related]
7. Sequestration of PDLIM2 in the cytoplasm of monocytic/macrophage cells is associated with adhesion and increased nuclear activity of NF-kappaB.
Healy NC; O'Connor R
J Leukoc Biol; 2009 Mar; 85(3):481-90. PubMed ID: 19052146
[TBL] [Abstract][Full Text] [Related]
8. Inactivation of the putative ubiquitin-E3 ligase PDLIM2 in classical Hodgkin and anaplastic large cell lymphoma.
Wurster KD; Hummel F; Richter J; Giefing M; Hartmann S; Hansmann ML; Kreher S; Köchert K; Krappmann D; Klapper W; Hummel M; Wenzel SS; Lenz G; Janz M; Dörken B; Siebert R; Mathas S
Leukemia; 2017 Mar; 31(3):602-613. PubMed ID: 27538486
[TBL] [Abstract][Full Text] [Related]
9. DNA methylation-dependent repression of PDZ-LIM domain-containing protein 2 in colon cancer and its role as a potential therapeutic target.
Qu Z; Yan P; Fu J; Jiang J; Grusby MJ; Smithgall TE; Xiao G
Cancer Res; 2010 Mar; 70(5):1766-72. PubMed ID: 20145149
[TBL] [Abstract][Full Text] [Related]
10. PDLIM2 suppression efficiently reduces tumor growth and invasiveness of human castration-resistant prostate cancer-like cells.
Kang M; Lee KH; Lee HS; Park YH; Jeong CW; Ku JH; Kim HH; Kwak C
Prostate; 2016 Feb; 76(3):273-85. PubMed ID: 26499308
[TBL] [Abstract][Full Text] [Related]
11. Causative role of PDLIM2 epigenetic repression in lung cancer and therapeutic resistance.
Sun F; Li L; Yan P; Zhou J; Shapiro SD; Xiao G; Qu Z
Nat Commun; 2019 Nov; 10(1):5324. PubMed ID: 31757943
[TBL] [Abstract][Full Text] [Related]
12. Kruppel like factor 10 up-regulates PDZ and LIM domain containing protein 2 via nuclear factor kappa-B pathway to inhibit proliferation and inflammatory of fibroblastoid synovial cell in rheumatoid arthritis.
Wang S; Zha X; Ruan S; Yao S; Zhang X
Bioengineered; 2022 Jan; 13(1):1779-1790. PubMed ID: 34713769
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic repression of PDZ-LIM domain-containing protein 2 promotes ovarian cancer via NOS2-derived nitric oxide signaling.
Zhao L; Yu C; Zhou S; Lau WB; Lau B; Luo Z; Lin Q; Yang H; Xuan Y; Yi T; Zhao X; Wei Y
Oncotarget; 2016 Jan; 7(2):1408-20. PubMed ID: 26593252
[TBL] [Abstract][Full Text] [Related]
14. Mystique is a new insulin-like growth factor-I-regulated PDZ-LIM domain protein that promotes cell attachment and migration and suppresses Anchorage-independent growth.
Loughran G; Healy NC; Kiely PA; Huigsloot M; Kedersha NL; O'Connor R
Mol Biol Cell; 2005 Apr; 16(4):1811-22. PubMed ID: 15659642
[TBL] [Abstract][Full Text] [Related]
15. PDLIM2 expression is driven by vitamin D and is involved in the pro-adhesion, and anti-migration and -invasion activity of vitamin D.
Vanoirbeek E; Eelen G; Verlinden L; Carmeliet G; Mathieu C; Bouillon R; O'Connor R; Xiao G; Verstuyf A
Oncogene; 2014 Apr; 33(15):1904-11. PubMed ID: 23584482
[TBL] [Abstract][Full Text] [Related]
16. PDLIM2 inhibits T helper 17 cell development and granulomatous inflammation through degradation of STAT3.
Tanaka T; Yamamoto Y; Muromoto R; Ikeda O; Sekine Y; Grusby MJ; Kaisho T; Matsuda T
Sci Signal; 2011 Dec; 4(202):ra85. PubMed ID: 22155789
[TBL] [Abstract][Full Text] [Related]
17. PDLIM2 Is a Marker of Adhesion and β-Catenin Activity in Triple-Negative Breast Cancer.
Cox OT; Edmunds SJ; Simon-Keller K; Li B; Moran B; Buckley NE; Bustamante-Garrido M; Healy N; O'Flanagan CH; Gallagher WM; Kennedy RD; Bernards R; Caldas C; Chin SF; Marx A; O'Connor R
Cancer Res; 2019 May; 79(10):2619-2633. PubMed ID: 30885980
[TBL] [Abstract][Full Text] [Related]
18. Essential function for PDLIM2 in cell polarization in three-dimensional cultures by feedback regulation of the β1-integrin-RhoA signaling axis.
Deevi RK; Cox OT; O'Connor R
Neoplasia; 2014 May; 16(5):422-31. PubMed ID: 24863845
[TBL] [Abstract][Full Text] [Related]
19. High Expression of PDLIM2 Predicts a Poor Prognosis in Prostate Cancer and Is Correlated with Epithelial-Mesenchymal Transition and Immune Cell Infiltration.
Piao S; Zheng L; Zheng H; Zhou M; Feng Q; Zhou S; Ke M; Yang H; Wang X
J Immunol Res; 2022; 2022():2922832. PubMed ID: 35707002
[TBL] [Abstract][Full Text] [Related]
20. Suppression of NF-κB activation by PDLIM2 restrains hepatic lipogenesis and inflammation in high fat diet induced mice.
Hao YR; Tang FJ; Zhang X; Wang H
Biochem Biophys Res Commun; 2018 Sep; 503(2):564-571. PubMed ID: 29852170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]